NASDAQ · TEM

Tempus AI, Inc.

$42.91 +$0.22 (+0.52%) 1D After hours

Key Metrics

$7.69B
Market cap
P/E · TTM
$1.36B
Revenue · TTM
−$302.91M
Net income
EPS · TTM $-1,776.54
Dividend yield
Free cash flow −$212.92M
Beta · 1Y 2.50
EBITDA · TTM −$237.30M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    A material event was filed (Form 8-K).

    8-K - Tempus AI, Inc. (0001717115) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 5
    The stock moved -11.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 5
  • Apr 15
    The stock moved +13.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 15
  • Mar 30
    From its Jan 29 high, the share price fell 33%.

    Peak close $63.51 on Jan 29; trough close $42.37 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.69B
Enterprise value
Shares outstanding180.1M
52-wk range$41.73 – $104.32
Avg volume · 20D6.9M
Net cash
Book value / share$2,442.17
IndustryServices-Computer Programming, Data Processing, Etc.
ExchangeNASDAQ
About Tempus AI, Inc.
IPO dateJun 14, 2024
Employees3800

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S5.63
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -19.7%
Net -22.2%
FCF -15.6%
ROE / ROIC -128.1% · 251.9%

Financial Health

Current ratio3.31
Quick ratio3.15
Debt / equity
Debt / EBITDA
Net cash
Working capital$735.99M

Cash Flow · TTM

Operating CF −$185.74M
Capex −$27.18M
Free cash flow −$212.92M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings